INS and Insulin resistance: NAFLD, hepatic iron load, and metabolic abnormalities such as increased fasting insulin, insulin resistance, and platelet count might be linked together, and treating patients at early stages might prevent extrahepatic complications as well as the adverse clinical outcomes.